| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |